What a Strong Type System Brings to the Roche Drug Discovery Pipeline by@danielcrowe
257 reads

What a Strong Type System Brings to the Roche Drug Discovery Pipeline

by Daniel Crowe6mJune 21st, 2021
Read on Terminal Reader
Read this story w/o Javascript
tldt arrow

Too Long; Didn't Read

Debrief from a Vaticle Community talk — featuring David Dylus, Scientist, Systems Biology, at Roche. David presents how his team at Roche was able to identify potential novel targets that were not identified by Open Targets as highly ranked. This was made possible with TypeDB, which his team used to store the relevant data and then find underlying biological evidence for those new targets. Three datasets were used: STRING, Oma, and DisGeNET. The team looked at existing targets and selected those already ranked highly and known to have a high association score.

Companies Mentioned

Mention Thumbnail
Mention Thumbnail
featured image - What a Strong Type System Brings to the Roche Drug Discovery Pipeline
Daniel Crowe HackerNoon profile picture
Daniel Crowe

Daniel Crowe

@danielcrowe

Chicago > NYC > London @ Vaticle

Learn More
LEARN MORE ABOUT @DANIELCROWE'S
EXPERTISE AND PLACE ON THE INTERNET.

Share Your Thoughts

About Author

Daniel Crowe HackerNoon profile picture
Daniel Crowe@danielcrowe
Chicago > NYC > London @ Vaticle

TOPICS

THIS ARTICLE WAS FEATURED IN...

Permanent on Arweave
Read on Terminal Reader
Read this story in a terminal
 Terminal
Read this story w/o Javascript
Read this story w/o Javascript
 Lite
L O A D I N G
. . . comments & more!